查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1863151

全球腦部影像診斷設備市場：洞察、競爭格局及市場預測（至2032年）

Brain Imaging Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

腦部影像診斷設備市場摘要

  • 全球腦部影像診斷設備市場預計將從 2024 年的 50.9171 億美元成長到 2032 年的 77.7985 億美元，反映出強勁且持續的成長。
  • 全球腦部影像設備市場在 2025 年至 2032 年的預測期內將以 5.50% 的複合年成長率成長。
  • 全球腦部影像診斷設備市場的發展動力來自神經系統疾病的日益普遍、技術進步（尤其是人工智慧和機器學習的融合）以及主要市場參與者不斷增加的產品開發活動，包括 MRI、CT 和 PET 技術的創新。
  • 腦造影診斷設備市場的主要企業包括西門子醫療私人有限公司、通用電氣醫療集團、皇家飛利浦公司、佳能醫療系統株式會社、日立高新技術公司、富士膠片控股株式會社、島津公司、Esaote SPA、Mediso Ltd.、三星電子有限公司、民方醫療系統有限公司、上海影聯醫療股份有限公司、Voxelidate Limiteds InMRations、上海民方醫療系統有限公司、上海影聯醫療有限公司Solutions、珀金埃爾默、金斯威生物科技有限公司、席勒、東軟醫療系統有限公司、時代醫療控股和科寧醫療。
  • 由於神經系統疾病的高發生率、強大的研發投入、先進的醫療基礎設施以及主要醫療設備公司不斷進行的技術創新，北美腦影像診斷設備市場在全球佔主導地位。
  • 根據產品類型，預計到 2024 年，設備類產品將佔最大的市場佔有率。

腦部影像診斷設備市場的成長要素

  • 神經系統疾病的日益普遍正推動腦影像市場的快速擴張：阿茲海默症、帕金森氏症、癲癇、中風、多發性硬化症和腦腫瘤等神經系統疾病在全球範圍內呈上升趨勢，這主要是由於人口老齡化以及肥胖、壓力和心血管疾病等生活方式相關的風險因素所致。由於這些疾病需要精準診斷和持續監測，MRI、CT 和 PET 等腦部影像設備變得至關重要。例如，MRI 有助於檢測阿茲海默症的腦萎縮，而 CT 和 PET 對於檢測中風和評估腫瘤至關重要。不斷成長的患者群體直接推動了臨床和研究領域對先進腦部影像技術的需求。
  • 人工智慧和機器學習等技術的進步將推動腦成像設備的普及：人工智慧 (AI) 和機器學習 (ML) 正在透過提高影像品質、增強診斷準確性和縮短報告時間來變革腦成像。例如，整合人工智慧的磁振造影 (MRI) 和正子斷層掃描 (PET) 系統現在能夠識別與阿茲海默症相關的澱粉樣蛋白和Tau沉積。此外，人工智慧賦能的工作流程自動化可以減輕臨床醫生的工作量，提高效率，並擴大診斷影像服務的覆蓋範圍，尤其是在大型醫院和遠端影像平台。
  • 主要企業加大產品研發力度：領先的醫療設備公司和新興企業正大力投資開發創新腦造影解決方案。這些解決方案包括用於照護現場的可攜式核磁共振造影系統、用於更全面成像診斷的PET/MRI混合平台，以及具有低劑量輻射和快速掃描功能的先進CT系統。飛利浦、西門子醫療、GE醫療和Hyperfine等公司正引領著下一代設備的研發，這些設備配備了人工智慧、增強硬體和專用的神經影像應用程式。持續的產品發布和監管核准不僅拓展了臨床效用，也提高了醫院、診斷中心和研究機構的採用率，從而推動了整體市場成長。

腦部影像診斷設備市場報告區隔

本研究報告全面概​​述了全球腦部影像診斷設備市場，重點闡述了關鍵趨勢、市場促進因素、挑戰和機會。報告按產品類型、應用、最終用戶和地區對腦成像診斷設備市場進行了深入分析，並深入剖析了北美、歐洲和亞太等主要市場的競爭格局、監管環境和市場動態。報告詳細介紹了行業領導者的概況和近期產品開發情況，為企業識別市場潛力、制定戰略規劃以及把握快速成長的腦成像診斷設備市場中的新機會提供了重要數據。

腦部影像設備是用於可視化大腦結構和功能的先進診斷工具，在檢測和監測阿茲海默症、中風、癲癇、帕金森氏症和腦腫瘤等神經系統疾病方面發揮關鍵作用。主要影像方式包括磁振造影（MRI）、電腦斷層掃描（CT）、正子斷層掃描（PET）、腦電圖（EEG）和腦磁圖（MEG），每種方式都提供獨特的結構、功能和代謝成像能力。受神經系統疾病盛行率上升、人口老化以及人工智慧影像、可攜式MRI系統和PET/MRI混合平台等持續技術進步的推動，腦影像市場正經歷快速成長。這些技術創新正在提高診斷準確性，實現早期檢測，並擴大已開發經濟體和新興經濟體醫療保健系統獲得高品質神經影像服務的途徑。

腦造影設備市場正因多種因素而穩定成長。阿茲海默症、帕金森氏症、中風、癲癇和腦腫瘤等神經系統疾病的日益普遍，催生了對能夠實現精準診斷和有效治療方案製定的先進影像解決方案的強勁需求。全球人口老化和生活方式相關的風險因素進一步加劇了這些疾病的發生率。技術進步，特別是人工智慧和機器學習在磁振造影（MRI）、電腦斷層掃描（CT）和正子斷層掃描（PET）系統中的應用，正在提升影像診斷的準確性、速度和診斷能力，從而改善臨床療效。此外，主要企業正加大產品研發力度，推出可攜式MRI系統、PET/MRI混合平台和人工智慧驅動的影像軟體等創新設備，以拓展臨床應用範圍並提高其可及性。這些因素，加上人們對早期診斷意識的不斷提高和醫療保健投資的持續成長，將繼續推動全球腦部影像設備市場的成長。

由於腦部腫瘤、中風、阿茲海默症、帕金森氏症和癲癇等神經系統疾病的盛行率不斷上升，腦部影像診斷設備市場正經歷顯著成長。人口老化和生活方式相關的風險因素共同推動了這一趨勢。技術進步，特別是人工智慧 (AI) 和機器學習 (ML) 的融合，進一步提高了成像精度、診斷速度和臨床決策能力，從而能夠實現更早期的檢測和更個性化的治療策略。同時，領先企業在磁振造影 (MRI)、電腦斷層掃描 (CT) 和正子斷層掃描 (PET) 技術方面的持續產品研發和創新，正在拓寬應用範圍，提高整體效率，並支持市場擴張。

根據DelveInsight統計，全球約有5,050萬人患有癲癇，其中近80%居住在中低收入國家。腦部影像檢查，例如磁振造影（MRI）、電腦斷層掃描（CT）和正子斷層掃描（PET），在檢測可能導致癲癇發作的結構異常、病變、腫瘤和疤痕方面發揮著至關重要的作用。因此，對先進影像技術的日益依賴已成為全球市場成長的主要推動力。同樣，分析師估計全球約有2100萬人患有腦出血（ICH）。在這種情況下，快速且準確的影像學檢查對於確定出血的位置、大小和原因，指導緊急內科和外科干預，以及區分腦出血和缺血性中風至關重要。 CT和MRI仍然是急診醫學中監測血腫發展和治療反應的重要工具。

人工智慧和機器學習的融合正在透過提高診斷準確性和簡化工作流程來加速市場發展。 Hyperfine 的 Swoop®可攜式磁振造影系統、飛利浦的 Smart Quant Neuro 3D 系統FUJIFILM的 ECHELON Synergy 系統等公司，都在將人工智慧功能整合到其磁共振成像 (MRI)、電腦斷層掃描 (CT) 和正子斷層掃描 (PET) 平台中，以最佳化影像品質並實現自動化報告。 2024 年 12 月，佳能醫療系統美國公司推出了 INSTINX 和 Vitrea 等工具，進一步擴展了其人工智慧賦能的 CT 產品組合，旨在加速診斷流程並提高臨床準確性。該產品組合還包括一些專注於臨床的軟體包，例如用於腦出血 (ICH)、大血管閉塞 (LVO) 和 CT 腦灌注成像的中風 CT 軟體包。

因此，疾病流行率上升、對準確診斷的需求增加以及技術快速創新等因素預計將在預測期內（即 2025-2032 年）推動全球腦部影像診斷設備市場強勁成長。

儘管需求不斷成長，但腦部影像診斷設備市場仍面臨許多阻礙因素，可能阻礙其擴張。其中一個主要挑戰是設備及持續維護成本高昂，因為諸如磁振造影（MRI）、電腦斷層掃描（CT）和正子斷層掃描（PET）等先進影像處理設備需要大量的資金投入、專門的基礎設施和持續的維護。這對於規模較小的醫院和診斷中心，尤其是在發展中地區，構成了一道障礙。另一個令人擔憂的問題是CT和PET等檢查方式帶來的輻射暴露風險，這會對病患安全構成威脅，特別是對於需要反覆檢查的弱勢族群。這些因素不僅影響購買決策，還會引發監管審查，限制設備的廣泛應用，進而影響整體市場成長。

腦部影像診斷設備市場區隔分析

腦部影像診斷設備市場按產品類型、應用、最終用戶和地區分類

腦部影像診斷設備市場區域分析

北美腦部影像診斷設備市場趨勢

以美國為首的北美地區將主導全球腦部影像診斷設備市場，到2024年將佔約41%的市場。北美腦部影像診斷設備市場正穩步擴張，這主要得益於神經系統疾病的高發生率、強勁的研發投入、先進的醫療基礎設施以及主要醫療設備公司持續不斷的技術創新。此外，人們對早期診斷意識的不斷提高以及尖端成像技術的廣泛應用進一步鞏固了該地區的領先地位，確保主導地位。

根據DelveInsight的分析，美國每年報告的阿茲海默症超過750萬人，預計到2050年，這個數字將幾乎加倍，達到1,300萬人。大約每九名65歲以上的老年人中就有一人受到影響，女性的風險更高。腦部影像在檢測老年失智症相關變化方面發揮關鍵作用，例如海馬萎縮、皮質變薄以及澱粉樣蛋白和Tau蛋白等有害蛋白質的累積。磁振造影（MRI）和正子斷層掃描（PET）等影像技術，特別是澱粉樣蛋白PET和TauPET，被廣泛應用於臨床和研究領域，以識別神經神經退化的早期標記、追蹤疾病進展並評估治療效果。

此外，腦腫瘤發生率的上升進一步推動了對先進成像技術的需求。截至2023年，美國約有100萬人罹患腦腫瘤。無論是惡性腫瘤還是良性腫瘤，都需要高解析度影像來確定其大小、位置以及與周圍腦組織的關係，這對於手術計劃、放射線治療和持續監測至關重要。磁振造影（MRI）仍然是腫瘤檢測的黃金標準，它能提供出色的軟組織對比度，從而可以精確地勾勒出腫瘤邊界並評估其潛在的侵襲性。

除了疾病流行之外，北美市場也受益於快速的技術創新和頻繁的產品發布。例如，在2024年12月的北美放射學會（RSNA）年會上，飛利浦在北美推出了其配備人工智慧的CT 5300系統。該系統整合了先進的硬體和人工智慧主導的智慧工作流程解決方案，旨在提高診斷信心、縮短掃描時間並提升高品質影像的獲取便利性。其自動患者定位、高精度腦部和心臟成像以及最佳化的輻射劑量等功能，使其特別適用於神經心血管應用和低劑量篩檢項目。

歐洲腦部影像診斷設備市場趨勢

由於阿茲海默症、失智症、中風和癲癇等神經系統疾病病例不斷增加，歐洲腦部造影設備市場正經歷強勁成長。這些疾病在該地區老齡化人口中日益普遍。推動市場發展的關鍵趨勢是將人工智慧整合到磁振造影（MRI）、電腦斷層掃描（CT）、正子斷層掃描（PET）和腦電圖（EEG）系統中，這將提高診斷準確性並簡化臨床工作流程。

此外，領先的醫療技術公司、研究機構和大學之間的合作正在加速PET/MRI和低場可攜式MRI等混合成像技術的應用。該地區雲端基礎成像平台和遠端影像服務的應用也日益普及，從而改善了專業診斷服務的可近性，尤其是在醫療資源匱乏的地區。此外，歐盟「地平線歐洲」等計畫對神經科學研究的投入不斷增加，刺激了創新；同時，對人工智慧醫療設備的監管支持也為新興企業和數位醫療公司創造了機會。

因此，歐洲腦造影設備市場呈現穩定成長的態勢，這得益於人口老化、先進的醫療保健系統以及對創新診斷和影像解決方案的重視。

亞太地區腦部影像診斷設備市場趨勢

亞太地區腦部影像設備市場正快速擴張，在2025年至2032年的預測期內，預計將以6.87%的強勁複合年成長率成長。推動這一成長的主要因素包括神經系統疾病盛行率的上升、醫療保健投資的增加以及先進診斷技術的快速普及。中國、日本、印度和韓國等國家已成為主要貢獻者，其不斷完善的醫院基礎設施、政府推行的早期診斷舉措以及日益增強的腦健康意識都促進了市場需求。日本持續引領技術創新，大力推廣高階MRI和PET系統；而中國則快速擴大國內生產能力，減少對進口的依賴。在印度，中風和失智症負擔的加重，以及城市地區先進影像技術的普及，都創造了巨大的商機。此外，人工智慧成像解決方案、遠端成像以及可攜式設備的整合應用在全部區域日益普及，使得神經影像學在農村地區也更容易獲得。全球設備製造商與當地企業之間的戰略夥伴關係、有利的監管改革以及醫療旅遊的支持性趨勢，正在進一步塑造亞太市場格局。

以下列出了腦部影像診斷設備市場的主要企業，它們總合佔最大的市場佔有率，並引領著產業趨勢：

  • Siemens Healthcare Private Limited
  • GE HealthCare
  • Koninklijke Philips NV
  • CANON MEDICAL SYSTEMS CORPORATION
  • Hitachi High-Tech Corporation
  • Fujifilm Holdings Corporation
  • Shimadzu Corporation
  • Esaote SPA
  • Mediso Ltd.
  • Samsung Electronics Co. Ltd
  • MinFound Medical Systems Co., Ltd.
  • Shanghai United Imaging Healthcare Co., Ltd.
  • Voxelgrids Innovations Private Limited
  • MR Solutions
  • PerkinElmer
  • Kindsway Biotech Co., Ltd.
  • SCHILLER
  • Neusoft Medical Systems Co., Ltd.
  • Time Medical Holding
  • Koning Health

腦影像設備市場的競爭格局高度集中，全球主要醫療技術公司、影像處理專家和新興創新者專注於人工智慧主導的解決方案。西門子醫療、通用電氣醫療、飛利浦醫療和佳能醫療系統等現有企業憑藉其豐富的產品系列和強大的全球分銷網路，在磁振造影（MRI）、電腦斷層掃描（CT）和正子斷層掃描（PET）影像領域佔市場主導地位。同時，一些專注於特定領域的企業和新興企業也在可攜式腦電圖（EEG）、腦磁圖（MEG）和功能成像設備以及透過機器學習和資料整合提高診斷準確性的軟體方面做出貢獻。隨著各公司尋求拓展神經病學、腫瘤學和精神病學領域的臨床應用，策略聯盟、併購和研究合作正日益影響市場格局。此外，混合成像系統和無創技術的發展，以及新興國家日益成長的需求，加劇了市場競爭，同時也為技術差異化和市場擴張鋪平了道路。

腦部影像設備市場的最新發展

  • Hyperfine, Inc. 是一家開創性的醫療技術公司，該公司於 2025 年 9 月推出了 Swoop® 系統，這是首個獲得 FDA 批准的用於腦部成像的 AI 驅動可攜式MRI 系統，徹底改變了腦成像技術。該公司宣布，其 Optive AI™ 軟體已獲得 CE 標誌和英國合格評定 (UKCA)核准。
  • 2025年3月，Hyperfine與NVIDIA合作，增強其Swoop可攜式磁振造影系統的人工智慧功能。 Swoop是全球首款獲得FDA核准的可攜式磁振造影設備，代表了便利神經影像技術的突破性進展。

腦部影像診斷設備市場區隔

  • 按產品類型分類的腦部影像診斷設備發展趨勢
  • 裝置
  • 磁振造影造影（MRI）
  • 電腦斷層掃描（CT/SPECT）
  • 正子斷層掃描（PET）
  • 其他
  • 配件和耗材
  • 按便攜性分類的腦部影像診斷設備發展趨勢
  • 固定類型
  • 可攜式的
  • 按應用領域分類的腦部影像診斷設備發展趨勢
  • 中風
  • 腦腫瘤
  • 癲癇
  • 其他
  • 腦部影像診斷設備終端用戶趨勢
  • 醫院
  • 診斷影像中心
  • 門診手術中心
  • 其他
  • 腦部影像診斷設備的區域趨勢
  • 北美腦部影像診斷設備市場
  • 美國腦部影像診斷設備市場
  • 加拿大腦部影像診斷設備市場
  • 墨西哥腦部影像診斷設備市場
  • 歐洲腦部影像診斷設備市場
  • 英國腦部影像設備市場
  • 德國腦部影像診斷設備市場
  • 法國腦部影像診斷設備市場
  • 義大利腦部影像診斷設備市場
  • 西班牙腦部影像診斷設備市場
  • 其他歐洲腦部影像診斷設備市場
  • 亞太地區腦部影像診斷設備市場
  • 中國腦部影像設備市場
  • 日本腦部影像診斷設備市場
  • 印度腦部影像診斷設備市場
  • 澳洲腦部影像診斷設備市場
  • 韓國腦部影像診斷設備市場
  • 亞太地區其他腦部影像診斷設備市場
  • 世界其他地區腦部影像診斷設備市場
  • 南美洲腦部影像診斷設備市場
  • 中東腦部影像診斷設備市場
  • 非洲腦部影像診斷設備市場

影響分析

人工智慧驅動的創新正在改變腦部影像市場，提高診斷準確率，簡化工作流程，並催生新的臨床應用。整合到磁振造影 (MRI)、電腦斷層掃描 (CT)、正子斷層掃描 (PET)、腦電圖 (EEG) 和腦磁圖 (MEG) 系統中的先進演算法，如今能夠檢測細微異常，自動解讀影像，並為中風、阿茲海默症、癲癇和腦腫瘤等神經系統疾病提供預測性見解。這些工具能夠減少診斷錯誤，加快決策速度，並支持早期療育策略。此外，人工智慧主導的平台正擴大應用於遠端放射學和雲端基礎成像解決方案，擴大了高品質神經影像的覆蓋範圍，即使在服務不足的地區也能受益。除了診斷之外，人工智慧在研究和藥物開發中也發揮關鍵作用，能夠精確繪製腦活動圖譜，監測治療效果，並支持臨床試驗。將深度學習和機器學習模型與腦部影像技術結合，正推動神經系統疾病診療產業朝著更個人化、數據主導的方向發展。

美國關稅對腦影像設備市場的影響分析：

美國對包括腦部影像系統（如MRI、CT和PET掃描儀）組件在內的醫療設備徵收關稅，正對市場產生顯著影響。許多腦部影像設備依賴專用組件、先進半導體和高精度電子元件，這些元件通常來自海外，尤其是中國、日本和歐盟。對這些進口產品徵收關稅會增加製造成本和採購成本，最終推高腦部造影系統的整體價格。這不僅迫使製造商自行承擔或轉嫁這些額外成本，還會影響醫院、診斷中心和研究機構的採購決策，尤其是預算有限的小型機構。此外，設備價格上漲可能會減緩美國對下一代影像處理技術的採用，並加劇大型都市區醫院與小型或農村醫療機構之間的醫療資源取得差距。同時，這些關稅也可能刺激國內創新和在地採購策略，因為企業會尋求減少對進口組件的依賴，從長遠來看，這可能會重塑競爭格局。

目錄

第1章 腦部影像診斷設備市場報告概述

  • 調查範圍
  • 市場區隔
  • 市場假設

第2章 腦部影像診斷設備市場摘要整理

  • 市場概覽

第3章：腦部影像診斷設備市場關鍵因素分析

  • 市場促進因素
    • 神經系統疾病盛行率不斷上升
    • 人工智慧和機器學習的融合等技術進步
    • 主要參與企業加大了產品開發活動。
  • 市場阻礙與課題
    • 高昂的設備和維護成本
    • 輻射暴露風險較高
  • 市場機遇
    • 可攜式成像設備和照護現場技術的使用日益增加。

第4章 影響分析

  • 人工智慧驅動的創新和應用
  • 美國關稅的影響分析

第5章 監理分析

  • 美國
  • 歐洲
  • 日本
  • 中國

第6章：腦部影像診斷設備市場：波特五力分析

第7章 腦部影像診斷設備市場評估

  • 依產品類型
    • 裝置
    • 配件和耗材
  • 透過便攜性
    • 靜止的
    • 可攜式的
  • 透過使用
    • 中風
    • 腦腫瘤
    • 癲癇
    • 其他
  • 最終用戶
    • 醫院
    • 診斷影像中心
    • 門診手術中心
  • 地區
    • 北美洲
    • 歐洲
    • 亞太地區
    • 其他地區

第8章 競爭情勢

第9章Start-Ups資金籌措與投資趨勢

第10章 腦部影像診斷設備市場中的公司與產品概況

  • Siemens Healthcare Private Limited
  • GE Healthcare
  • Koninklijke Philips NV
  • CANON MEDICAL SYSTEMS CORPORATION
  • Hitachi High-Tech Corporation
  • Fujifilm Holdings Corporation
  • Shimadzu Corporation
  • Esaote SPA
  • Mediso Ltd.
  • Samsung Electronics Co. Ltd
  • MinFound Medical Systems Co., Ltd.
  • Shanghai United Imaging Healthcare Co., Ltd.
  • Voxelgrids Innovations Private Limited
  • MR Solutions
  • PerkinElmer
  • Kindsway Biotech Co., Ltd.
  • SCHILLER
  • Neusoft Medical Systems Co., Ltd.
  • Time Medical Holding
  • Koning Health

第11章：KOL視角

第12章計劃方法

第13章：關於 DelveInsight

第14章 免責聲明和聯絡我們

Product Code: DIMDCL0842

Brain Imaging Devices Market Summary

  • The global brain imaging devices market is expected to increase from USD 5,091.71 million in 2024 to USD 7,779.85 million by 2032, reflecting strong and sustained growth.
  • The global brain imaging devices market is growing at a CAGR of 5.50% during the forecast period from 2025 to 2032.
  • The global brain imaging devices market is driven by the rising prevalence of neurological disorders, technological advancements, especially AI and ML integration, and increasing product development activities by key market players, including innovations in MRI, CT, and PET technologies.
  • The leading companies operating in the brain imaging devices market include Siemens Healthcare Private Limited, GE HealthCare, Koninklijke Philips N.V., CANON MEDICAL SYSTEMS CORPORATION, Hitachi High-Tech Corporation, Fujifilm Holdings Corporation, Shimadzu Corporation, Esaote SPA, Mediso Ltd., Samsung Electronics Co. Ltd, MinFound Medical Systems Co., Ltd., Shanghai United Imaging Healthcare Co., Ltd., Voxelgrids Innovations Private Limited, MR Solutions, PerkinElmer, Kindsway Biotech Co., Ltd., SCHILLER, Neusoft Medical Systems Co., Ltd., Time Medical Holding, Koning Health, and others.
  • The North American brain imaging devices market is a dominant force globally, driven by the high prevalence of neurological disorders, strong R&D investment, advanced healthcare infrastructure, and continuous innovation by leading medical device companies.
  • In the product type segment of the brain imaging devices market, the devices category is estimated to account for the largest market share in 2024.

Factors Contributing to the Growth of the Brain Imaging Devices Market

  • The rising prevalence of neurological disorders is leading to a surge in the brain imaging devices market: Neurological conditions such as Alzheimer's disease, Parkinson's disease, epilepsy, stroke, multiple sclerosis, and brain tumors are increasing globally, primarily due to aging populations and lifestyle-related risk factors like obesity, stress, and cardiovascular disease. These disorders require accurate diagnosis and continuous monitoring, making brain imaging devices such as MRI, CT, and PET scanners essential. For instance, MRI helps detect brain shrinkage in Alzheimer's, while CT and PET are crucial for stroke detection and tumor evaluation. The growing patient pool directly drives the demand for advanced brain imaging technologies in both clinical and research settings.
  • Technological advancements such as the integration of AI and ML lead to higher adoption of brain imaging devices: Artificial intelligence (AI) and machine learning (ML) are transforming brain imaging by improving image quality, enhancing diagnostic precision, and reducing reporting time. AI-powered tools can detect subtle abnormalities, automate image segmentation, and even predict disease progression, supporting earlier and more personalized treatment decisions. For example, AI-integrated MRI and PET systems are now capable of identifying amyloid and tau protein deposits linked to Alzheimer's disease. Additionally, workflow automation enabled by AI reduces clinician workload, improves efficiency, and expands access to imaging services, particularly in high-volume hospitals and tele-radiology platforms.
  • Increase in product development activities among key players: Leading medical device companies and startups are heavily investing in the development of innovative brain imaging solutions. These include portable MRI devices for point-of-care diagnostics, hybrid PET/MRI platforms for more comprehensive imaging, and advanced CT systems with low-dose radiation and faster scanning capabilities. Companies like Philips, Siemens Healthineers, GE Healthcare, and Hyperfine are at the forefront of introducing next-generation devices equipped with AI, enhanced hardware, and specialized neuroimaging applications. Continuous product launches and regulatory approvals not only expand clinical utility but also increase adoption across hospitals, diagnostic centers, and research institutes, boosting overall market growth.

Brain Imaging Devices Market Report Segmentation

This brain imaging devices market report offers a comprehensive overview of the global Brain Imaging Devices market, highlighting key trends, growth drivers, challenges, and opportunities. It covers detailed market segmentation Brain Imaging Devices Market by Product Type (Devices [Magnetic Resonance Imaging (MRI), Computed Tomography (CT/SPECT), Positron Emission Tomography (PET), and Others] and Accessories & Consumables), Portability (Stationary and Portable), Application (Stroke, Brain Tumor, Epilepsy, and Others), End-User (Hospitals, Diagnostic Imaging Centers, Ambulatory Surgery Centers, and Others), and geography. The report provides valuable insights into the competitive landscape, regulatory environment, and market dynamics across major markets, including North America, Europe, and Asia-Pacific. Featuring in-depth profiles of leading industry players and recent product innovations, this report equips businesses with essential data to identify market potential, develop strategic plans, and capitalize on emerging opportunities in the rapidly growing Brain Imaging Devices market.

Brain imaging devices are advanced diagnostic tools used to visualize the structure and function of the brain, playing a crucial role in detecting and monitoring neurological disorders such as Alzheimer's, stroke, epilepsy, Parkinson's disease, and brain tumors. Key modalities include MRI, CT, PET, EEG, and MEG, each offering unique capabilities for structural, functional, and metabolic imaging. The market is growing rapidly, fueled by rising neurological disease prevalence, an aging population, and continuous technological advancements such as AI-powered imaging, portable MRI systems, and hybrid PET/MRI platforms. These innovations are improving diagnostic accuracy, enabling early detection, and expanding access to high-quality neuroimaging across both developed and emerging healthcare systems.

The brain imaging devices market is witnessing steady growth, driven by multiple factors. The rising prevalence of neurological disorders such as Alzheimer's disease, Parkinson's disease, stroke, epilepsy, and brain tumors has created a strong demand for advanced imaging solutions that enable accurate diagnosis and effective treatment planning. An aging global population, coupled with lifestyle-related risk factors, is further contributing to the growing incidence of these conditions. Technological advancements, particularly the integration of artificial intelligence and machine learning into MRI, CT, and PET systems, are improving imaging accuracy, speed, and diagnostic capabilities, thereby enhancing clinical outcomes. In addition, leading market players are intensifying product development activities, introducing innovative devices such as portable MRI systems, hybrid PET/MRI platforms, and AI-driven imaging software to expand clinical applications and accessibility. These factors, combined with increasing awareness of early diagnosis and rising healthcare investments, continue to propel the growth of the brain imaging devices market worldwide.

What are the latest Brain Imaging Devices Market Dynamics and Trends?

The brain imaging devices market is experiencing significant growth, largely driven by the increasing prevalence of neurological disorders such as brain tumors, strokes, Alzheimer's disease, Parkinson's disease, and epilepsy. This trend is fueled by both aging demographics and lifestyle-related risk factors. Technological advancements, particularly the integration of artificial intelligence (AI) and machine learning (ML), are further enhancing imaging accuracy, diagnostic speed, and clinical decision-making, enabling earlier detection and more personalized treatment strategies. In parallel, continuous product development and innovation in MRI, CT, and PET technologies by leading players are broadening the scope of applications and improving overall efficiency, collectively propelling market expansion.

According to DelveInsight, around 50.5 million people worldwide are affected by epilepsy, with nearly 80% residing in low- and middle-income countries. Brain imaging modalities such as MRI, CT, and PET scans play a crucial role in detecting structural abnormalities, lesions, tumors, or scarring responsible for seizures. This growing reliance on advanced imaging to support accurate epilepsy diagnosis is emerging as a key driver of global market growth. Similarly, analysts estimate that nearly 21 million people globally are living with intracerebral hemorrhage (ICH). In such cases, rapid and precise imaging is essential to identify the location, size, and cause of bleeding, guide urgent medical or surgical interventions, and distinguish ICH from ischemic stroke. CT and MRI remain indispensable tools in emergency care for monitoring hematoma development and treatment response.

The integration of AI and ML is accelerating market momentum by refining diagnostic precision and streamlining workflows. Companies such as Hyperfine with its Swoop(R) Portable MRI, Philips with Smart Quant Neuro 3D, and Fujifilm with ECHELON Synergy are embedding AI capabilities into MRI, CT, and PET platforms to optimize image quality and automate reporting. In December 2024, Canon Medical Systems USA expanded its AI-enabled CT portfolio by launching tools such as INSTINX and Vitrea, designed to accelerate diagnostic processes and improve clinical accuracy. The portfolio also featured specialized clinical packages, including a Stroke CT Package with applications for intracerebral hemorrhage (ICH), large vessel occlusion (LVO), and CT brain perfusion.

Therefore, these factors, including rising disease prevalence, growing demand for precise diagnostics, and rapid technological innovation, are expected to drive strong growth in the global brain imaging devices market throughout the forecast period of 2025 to 2032.

Despite the growing demand, the brain imaging devices market faces several restraints that could hinder its expansion. One of the primary challenges is the high cost of equipment and ongoing maintenance, as advanced imaging modalities like MRI, CT, and PET scanners require significant capital investment, specialized infrastructure, and continuous servicing. This creates a barrier for smaller hospitals and diagnostic centers, particularly in developing regions. Another concern is the risk of radiation exposure associated with modalities such as CT and PET, which raises patient safety issues, especially for vulnerable groups requiring repeated scans. These factors not only influence purchasing decisions but also drive regulatory scrutiny and limit widespread adoption, thereby impacting overall market growth.

Brain Imaging Devices Market Segment Analysis

Brain Imaging Devices Market by Product Type (Devices [Magnetic Resonance Imaging (MRI), Computed Tomography (CT/SPECT), Positron Emission Tomography (PET), and Others] and Accessories & Consumables), Portability (Stationary and Portable), Application (Stroke, Brain Tumor, Epilepsy, and Others), End-User (Hospitals, Diagnostic Imaging Centers, Ambulatory Surgery Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

Brain Imaging Devices Market Regional Analysis

North America Brain Imaging Devices Market Trends

North America, led by the United States, dominates the global brain imaging devices market, accounting for approximately 41% of the total market share in 2024. The North American brain imaging devices market is expanding steadily, driven by the high prevalence of neurological disorders, strong R&D investments, advanced healthcare infrastructure, and continuous innovation from leading medical device companies. The region's dominance is further reinforced by growing awareness of early diagnosis and broad adoption of cutting-edge imaging technologies, securing its leading position in the global landscape.

According to DelveInsight analysis, more than 7.5 million people in the U.S. were living with Alzheimer's disease in the reported year, with the number projected to nearly double to 13 million by 2050. Approximately one in nine individuals aged 65 and above is affected, with women facing a higher risk. Brain imaging plays a vital role in detecting Alzheimer-related changes, such as hippocampal shrinkage, cortical thinning, and the accumulation of harmful proteins like amyloid and tau. Modalities such as magnetic resonance imaging (MRI) and positron emission tomography (PET), particularly amyloid PET and tau PET, are extensively used in clinical and research settings to identify early markers of neurodegeneration, track disease progression, and assess treatment efficacy.

In addition, the burden of brain tumors further highlights the critical need for advanced imaging technologies. As of 2023, nearly one million people in the U.S. were living with a brain tumor. Both malignant and benign tumors require high-resolution imaging to determine size, location, and relationship to surrounding brain structures, which is crucial for surgical planning, radiation therapy, and ongoing monitoring. MRI remains the gold standard for tumor detection, offering exceptional soft tissue contrast that enables accurate delineation of tumor boundaries and assessment of potential infiltration.

Beyond disease prevalence, the North American market benefits significantly from rapid technological innovation and frequent product launches. For instance, in December 2024 at RSNA, Philips introduced its AI-powered CT 5300 system in North America. The system integrates advanced hardware with AI-driven Smart Workflow solutions to enhance diagnostic confidence, reduce scan time, and improve accessibility to high-quality imaging. Features such as automated patient positioning, precise brain and cardiac imaging, and optimized radiation dosing make it particularly suitable for both neurological and cardiovascular applications, as well as low-dose screening programs.

Europe Brain Imaging Devices Market Trends

The Europe brain imaging devices market is witnessing strong growth driven by rising cases of neurological disorders such as Alzheimer's disease, dementia, stroke, and epilepsy, which are increasingly prevalent in the region's aging population. Governments and healthcare systems across Europe are investing heavily in early diagnosis and advanced neuroimaging infrastructure, supported by favorable reimbursement frameworks in countries like Germany, France, and the U.K. A major trend shaping the market is the integration of artificial intelligence into MRI, CT, PET, and EEG systems, which enhances diagnostic precision and streamlines clinical workflows.

In addition, collaborations between leading medtech companies, research institutes, and universities are accelerating the adoption of hybrid imaging technologies such as PET/MRI and low-field portable MRI solutions. The region is also seeing significant uptake of cloud-based imaging platforms and tele-radiology services, which improve access to specialized diagnostics, particularly in underserved areas. Furthermore, increased funding for neuroscience research under EU programs like Horizon Europe is driving innovation, while regulatory support for AI-based medical devices is creating opportunities for startups and digital health companies.

Hence, the Europe brain imaging devices market is characterized by steady growth, shaped by aging demographics, advanced healthcare systems, and a strong focus on innovative diagnostic and imaging solutions.

Asia-Pacific Brain Imaging Devices Market Trends

The Asia-Pacific brain imaging devices market is witnessing rapid expansion, reflecting a robust CAGR of 6.87% during the forecast period from 2025 to 2032, driven by the rising prevalence of neurological disorders, increasing healthcare investments, and rapid adoption of advanced diagnostic technologies. Countries such as China, Japan, India, and South Korea are emerging as key contributors, with expanding hospital infrastructure, government initiatives for early diagnosis, and growing awareness about brain health fueling demand. Japan continues to lead in technological innovation with strong adoption of high-end MRI and PET systems, while China is rapidly expanding its domestic manufacturing capabilities to reduce reliance on imports. In India, the increasing burden of stroke and dementia, coupled with improving access to advanced imaging modalities in urban centers, is creating significant opportunities. Additionally, the integration of AI-driven imaging solutions, tele-radiology, and portable devices is gaining traction across the region, making neuroimaging more accessible even in rural areas. Strategic partnerships between global device manufacturers and local players, along with favorable regulatory reforms and supportive medical tourism trends, are further shaping the market outlook in Asia-Pacific.

Who are the major players in the Brain Imaging Devices Market?

The following are the leading companies in the brain imaging devices market. These companies collectively hold the largest market share and dictate industry trends.

  • Siemens Healthcare Private Limited
  • GE HealthCare
  • Koninklijke Philips N.V.
  • CANON MEDICAL SYSTEMS CORPORATION
  • Hitachi High-Tech Corporation
  • Fujifilm Holdings Corporation
  • Shimadzu Corporation
  • Esaote SPA
  • Mediso Ltd.
  • Samsung Electronics Co. Ltd
  • MinFound Medical Systems Co., Ltd.
  • Shanghai United Imaging Healthcare Co., Ltd.
  • Voxelgrids Innovations Private Limited
  • MR Solutions
  • PerkinElmer
  • Kindsway Biotech Co., Ltd.
  • SCHILLER
  • Neusoft Medical Systems Co., Ltd.
  • Time Medical Holding
  • Koning Health

How is the competitive landscape shaping the Brain Imaging Devices Market?

The competitive landscape of the brain imaging devices market is characterized by a high degree of market concentration with the presence of leading global medical technology companies, specialized imaging firms, and emerging innovators focusing on AI-driven solutions. Established players such as Siemens Healthineers, GE Healthcare, Philips Healthcare, and Canon Medical Systems dominate the market through extensive product portfolios in MRI, CT, and PET imaging, along with strong global distribution networks. At the same time, niche companies and startups are contributing with advancements in portable EEG, MEG, and functional imaging devices, as well as software that enhances diagnostic accuracy through machine learning and data integration. Strategic collaborations, mergers and acquisitions, and partnerships with research institutions are increasingly shaping competition, as firms seek to expand their clinical applications in neurology, oncology, and psychiatry. Moreover, the push towards hybrid imaging systems and non-invasive techniques, combined with growing demand in emerging economies, is intensifying rivalry while opening avenues for technological differentiation and market expansion.

Recent Developmental Activities in the Brain Imaging Devices Market

  • In September 2025, Hyperfine, Inc., a pioneering health technology company that revolutionized brain imaging with the launch of the Swoop(R) system, the first FDA-cleared AI-powered portable MRI for the brain, announced that its Optive AI(TM) software received both CE Marking and UK Conformity Assessment (UKCA) approval.
  • In March 2025, Hyperfine partnered with NVIDIA to enhance the artificial intelligence capabilities of its Swoop Portable MRI system. Recognized as the world's first FDA-approved portable magnetic resonance brain imaging device, Swoop represents a breakthrough in accessible neuroimaging.

Brain Imaging Devices Market Segmentation

  • Brain Imaging Devices by Product Type Exposure
  • Device
  • Magnetic Resonance Imaging (MRI)
  • Computed Tomography (CT/SPECT)
  • Positron Emission Tomography (PET)
  • Others
  • Accessories and Consumables
  • Brain Imaging Devices Portability Exposure
  • Staionary
  • Portable
  • Brain Imaging Devices Application Exposure
  • Stroke
  • Brain Tumor
  • Epilepsy
  • Others
  • Brain Imaging Devices End-User Exposure
  • Hospitals
  • Diagnostic Imaging Centers
  • Ambulatory Surgery Centers
  • Others
  • Brain Imaging Devices Geography Exposure
  • North America Brain Imaging Devices Market
  • United States Brain Imaging Devices Market
  • Canada Brain Imaging Devices Market
  • Mexico Brain Imaging Devices Market
  • Europe Brain Imaging Devices Market
  • United Kingdom Brain Imaging Devices Market
  • Germany Brain Imaging Devices Market
  • France Brain Imaging Devices Market
  • Italy Brain Imaging Devices Market
  • Spain Brain Imaging Devices Market
  • Rest of Europe Brain Imaging Devices Market
  • Asia-Pacific Brain Imaging Devices Market
  • China Brain Imaging Devices Market
  • Japan Brain Imaging Devices Market
  • India Brain Imaging Devices Market
  • Australia Brain Imaging Devices Market
  • South Korea Brain Imaging Devices Market
  • Rest of Asia-Pacific Brain Imaging Devices Market
  • Rest of the World Brain Imaging Devices Market
  • South America Brain Imaging Devices Market
  • Middle East Brain Imaging Devices Market
  • Africa Brain Imaging Devices Market

Impact Analysis

AI-Powered Innovations and Applications:

AI-powered innovations are transforming the brain imaging devices market by enhancing diagnostic accuracy, improving workflow efficiency, and enabling new clinical applications. Advanced algorithms integrated into MRI, CT, PET, EEG, and MEG systems are now capable of detecting subtle abnormalities, automating image interpretation, and providing predictive insights into neurological conditions such as stroke, Alzheimer's disease, epilepsy, and brain tumors. These tools reduce diagnostic errors, accelerate decision-making, and support early intervention strategies. Additionally, AI-driven platforms are increasingly being used in tele-radiology and cloud-based imaging solutions, expanding access to high-quality neuroimaging in underserved regions. Beyond diagnostics, AI is also playing a vital role in research and drug development, allowing for precise mapping of brain activity, monitoring treatment outcomes, and supporting clinical trials. By integrating deep learning and machine learning models with brain imaging modalities, the industry is moving toward more personalized and data-driven approaches to neurological care.

U.S. Tariff Impact Analysis on the Brain Imaging Devices Market:

The imposition of U.S. tariffs on medical devices, including components used in brain imaging systems such as MRI, CT, and PET scanners, has had a notable impact on the market. Many brain imaging devices rely on specialized parts, advanced semiconductors, and high-precision electronics that are often sourced from overseas, particularly from regions like China, Japan, and the European Union. Tariffs on these imports increase manufacturing and procurement costs, ultimately driving up the overall price of brain imaging systems. This not only puts pressure on manufacturers to absorb or pass on additional costs but also affects purchasing decisions by hospitals, diagnostic centers, and research institutions, especially smaller facilities with limited budgets. Moreover, higher equipment prices may slow down the adoption of next-generation imaging technologies in the U.S., potentially widening the gap in accessibility between large urban hospitals and smaller or rural healthcare providers. At the same time, these tariffs could encourage domestic innovation and local sourcing strategies, as companies seek to reduce dependency on imported components, thereby reshaping the competitive landscape over the long term.

How This Analysis Helps Clients

  • Cost Management: By understanding the tariff landscape, clients can anticipate cost increases and adjust pricing strategies accordingly, ensuring profitability.
  • Supply Chain Optimization: Clients can identify alternative sourcing options and diversify their supply chains to reduce dependency on high-tariff regions, enhancing resilience.
  • Regulatory Navigation: Expert guidance on navigating the evolving regulatory environment helps clients maintain compliance and avoid potential legal challenges.
  • Strategic Planning: Insights into tariff impacts enable clients to make informed decisions about manufacturing locations, partnerships, and market entry strategies.

Key takeaways from the Brain Imaging Devices market report study

  • Market size analysis for the current brain imaging devices market size (2024), and market forecast for 8 years (2025 to 2032)
  • Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
  • Key companies dominating the brain imaging devices market.
  • Various opportunities available for the other competitors in the brain imaging devices market space.
  • What are the top-performing segments in 2024? How these segments will perform in 2032?
  • Which are the top-performing regions and countries in the current brain imaging devices market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for the brain imaging devices market growth in the future?

Frequently Asked Questions for the Brain Imaging Devices Market

1. What is the growth rate of the brain imaging devices market?

  • The brain imaging devices market is estimated to grow at a CAGR of 5.50% during the forecast period from 2025 to 2032.

2. What is the market for brain imaging devices?

  • The brain imaging devices market was valued at USD 5,091.71 million in 2024, and is expected to reach USD 7,779.85 million by 2032.

3. Which region has the highest share in the brain imaging devices market?

  • The North American brain imaging devices market is a dominant force globally, driven by the high prevalence of neurological disorders, strong R&D investment, advanced healthcare infrastructure, and continuous innovation by leading medical device companies.

4. What are the drivers for the brain imaging devices market?

  • The global brain imaging devices market is driven by the rising prevalence of neurological disorders, technological advancements, especially AI and ML integration, and increasing product development activities by key market players, including innovations in MRI, CT, and PET technologies.

5. Who are the key players operating in the brain imaging devices market?

  • Some of the key market players operating in the brain imaging devices market Siemens Healthcare Private Limited, GE HealthCare, Koninklijke Philips N.V., CANON MEDICAL SYSTEMS CORPORATION, Hitachi High-Tech Corporation, Fujifilm Holdings Corporation, Shimadzu Corporation, Esaote SPA, Mediso Ltd., Samsung Electronics Co. Ltd, MinFound Medical Systems Co., Ltd., Shanghai United Imaging Healthcare Co., Ltd., Voxelgrids Innovations Private Limited, MR Solutions, PerkinElmer, Kindsway Biotech Co., Ltd., SCHILLER, Neusoft Medical Systems Co., Ltd., Time Medical Holding, Koning Health, and Others.

Table of Contents

1. Brain Imaging Devices Market Report Introduction

  • 1.1 Scope of the Study
  • 1.2 Market Segmentation
  • 1.3 Market Assumption

2. Brain Imaging Devices Market Executive Summary

  • 2.1 Market at Glance

3. Brain Imaging Devices Market Key Factors Analysis

  • 3.1 Brain Imaging Devices Market Drivers
    • 3.1.1 The rising prevalence of neurological disorders
    • 3.1.2 Technological advancements such as the integration of AI and ML
    • 3.1.3 Increase in product development activities among the key players
  • 3.2 Brain Imaging Devices Market Restraints and Challenges
    • 3.2.1 High cost of equipment and maintenance
    • 3.2.2 High risk of radiation exposure
  • 3.3 Brain Imaging Devices Market Opportunity
    • 3.3.1 Increase in the use of portable imaging devices and point-of-care diagnostics.

4. Impact Analysis

  • 4.1 AI-Powered Innovations and Applications
  • 4.2 U.S. Tariff Impact Analysis

5. Regulatory Analysis

  • 5.1 The United States
  • 5.2 Europe
  • 5.3 Japan
  • 5.4 China

6. Brain Imaging Devices Market Porter's Five Forces Analysis

  • 6.1 Bargaining Power of Suppliers
  • 6.2 Bargaining Power of Consumers
  • 6.3 Threat of New Entrants
  • 6.4 Threat of Substitutes
  • 6.5 Competitive Rivalry

7. Brain Imaging Devices Market Assessment

  • 7.1 By Product Type
    • 7.1.1 Device
      • 7.1.1.1 Magnetic Resonance Imaging (MRI)
      • 7.1.1.2 Computed Tomography (CT/SPECT)
      • 7.1.1.3 Positron Emission Tomography (PET)
      • 7.1.1.4 Others
    • 7.1.2 Accessories and Consumables
  • 7.2 By Portability
    • 7.2.1 Staionary
    • 7.2.2 Portable
  • 7.3 By Application
    • 7.3.1 Stroke
    • 7.3.2 Brain Tumor
    • 7.3.3 Epilepsy
    • 7.3.4 Others
  • 7.4 By End-User
    • 7.4.1 Hospitals
    • 7.4.2 Diagnostic Imaging Centers
    • 7.4.3 Ambulatory Surgery Centers
    • 7.4.4 Others
  • 7.5 By Geography
    • 7.5.1 North America
      • 7.5.1.1 United States Brain Imaging Devices Market Size in USD million (2022-2032)
      • 7.5.1.2 Canada Brain Imaging Devices Market Size in USD million (2022-2032)
      • 7.5.1.3 Mexico Brain Imaging Devices Market Size in USD million (2022-2032)
    • 7.5.2 Europe
      • 7.5.2.1 France Brain Imaging Devices Market Size in USD million (2022-2032)
      • 7.5.2.2 Germany Brain Imaging Devices Market Size in USD million (2022-2032)
      • 7.5.2.3 United Kingdom Brain Imaging Devices Market Size in USD million (2022-2032)
      • 7.5.2.4 Italy Brain Imaging Devices Market Size in USD million (2022-2032)
      • 7.5.2.5 Spain Brain Imaging Devices Market Size in USD million (2022-2032)
      • 7.5.2.6 Rest of Europe Brain Imaging Devices Market Size in USD million (2022-2032)
    • 7.5.3 Asia-Pacific
      • 7.5.3.1 China Brain Imaging Devices Market Size in USD million (2022-2032)
      • 7.5.3.2 Japan Brain Imaging Devices Market Size in USD million (2022-2032)
      • 7.5.3.3 India Brain Imaging Devices Market Size in USD million (2022-2032)
      • 7.5.3.4 Australia Brain Imaging Devices Market Size in USD million (2022-2032)
      • 7.5.3.5 South Korea Brain Imaging Devices Market Size in USD million (2022-2032)
      • 7.5.3.6 Rest of Asia-Pacific Brain Imaging Devices Market Size in USD million (2022-2032)
    • 7.5.4 Rest of the World (RoW)
      • 7.5.4.1 Middle East Brain Imaging Devices Market Size in USD million (2022-2032)
      • 7.5.4.2 Africa Brain Imaging Devices Market Size in USD million (2022-2032)
      • 7.5.4.3 South America Brain Imaging Devices Market Size In USD Million (2022-2032)

8. Competitive Landscape

9. Startup Funding & Investment Trends

10. Brain Imaging Devices Market Company and Product Profiles

  • 10.1 Siemens Healthcare Private Limited
    • 10.1.1 Company Overview
    • 10.1.2 Company Snapshot
    • 10.1.3 Financial Overview
    • 10.1.4 Product Listing
    • 10.1.5 Entropy
  • 10.2 GE HealthCare
    • 10.2.1 Company Overview
    • 10.2.2 Company Snapshot
    • 10.2.3 Financial Overview
    • 10.2.4 Product Listing
    • 10.2.5 Entropy
  • 10.3 Koninklijke Philips N.V.
    • 10.3.1 Company Overview
    • 10.3.2 Company Snapshot
    • 10.3.3 Financial Overview
    • 10.3.4 Product Listing
    • 10.3.5 Entropy
  • 10.4 CANON MEDICAL SYSTEMS CORPORATION
    • 10.4.1 Company Overview
    • 10.4.2 Company Snapshot
    • 10.4.3 Financial Overview
    • 10.4.4 Product Listing
    • 10.4.5 Entropy
  • 10.5 Hitachi High-Tech Corporation
    • 10.5.1 Company Overview
    • 10.5.2 Company Snapshot
    • 10.5.3 Financial Overview
    • 10.5.4 Product Listing
    • 10.5.5 Entropy
  • 10.6 Fujifilm Holdings Corporation
    • 10.6.1 Company Overview
    • 10.6.2 Company Snapshot
    • 10.6.3 Financial Overview
    • 10.6.4 Product Listing
    • 10.6.5 Entropy
  • 10.7 Shimadzu Corporation
    • 10.7.1 Company Overview
    • 10.7.2 Company Snapshot
    • 10.7.3 Financial Overview
    • 10.7.4 Product Listing
    • 10.7.5 Entropy
  • 10.8 Esaote SPA
    • 10.8.1 Company Overview
    • 10.8.2 Company Snapshot
    • 10.8.3 Financial Overview
    • 10.8.4 Product Listing
    • 10.8.5 Entropy
  • 10.9 Mediso Ltd.
    • 10.9.1 Company Overview
    • 10.9.2 Company Snapshot
    • 10.9.3 Financial Overview
    • 10.9.4 Product Listing
    • 10.9.5 Entropy
  • 10.10 Samsung Electronics Co. Ltd
    • 10.10.1 Company Overview
    • 10.10.2 Company Snapshot
    • 10.10.3 Financial Overview
    • 10.10.4 Product Listing
    • 10.10.5 Entropy
  • 10.11 MinFound Medical Systems Co., Ltd.
    • 10.11.1 Company Overview
    • 10.11.2 Company Snapshot
    • 10.11.3 Financial Overview
    • 10.11.4 Product Listing
    • 10.11.5 Entropy
  • 10.12 Shanghai United Imaging Healthcare Co., Ltd.
    • 10.12.1 Company Overview
    • 10.12.2 Company Snapshot
    • 10.12.3 Financial Overview
    • 10.12.4 Product Listing
    • 10.12.5 Entropy
  • 10.13 Voxelgrids Innovations Private Limited
    • 10.13.1 Company Overview
    • 10.13.2 Company Snapshot
    • 10.13.3 Financial Overview
    • 10.13.4 Product Listing
    • 10.13.5 Entropy
  • 10.14 MR Solutions
    • 10.14.1 Company Overview
    • 10.14.2 Company Snapshot
    • 10.14.3 Financial Overview
    • 10.14.4 Product Listing
    • 10.14.5 Entropy
  • 10.15 PerkinElmer
    • 10.15.1 Company Overview
    • 10.15.2 Company Snapshot
    • 10.15.3 Financial Overview
    • 10.15.4 Product Listing
    • 10.15.5 Entropy
  • 10.16 Kindsway Biotech Co., Ltd.
    • 10.16.1 Company Overview
    • 10.16.2 Company Snapshot
    • 10.16.3 Financial Overview
    • 10.16.4 Product Listing
    • 10.16.5 Entropy
  • 10.17 SCHILLER
    • 10.17.1 Company Overview
    • 10.17.2 Company Snapshot
    • 10.17.3 Financial Overview
    • 10.17.4 Product Listing
    • 10.17.5 Entropy
  • 10.18 Neusoft Medical Systems Co., Ltd.
    • 10.18.1 Company Overview
    • 10.18.2 Company Snapshot
    • 10.18.3 Financial Overview
    • 10.18.4 Product Listing
    • 10.18.5 Entropy
  • 10.19 Time Medical Holding
    • 10.19.1 Company Overview
    • 10.19.2 Company Snapshot
    • 10.19.3 Financial Overview
    • 10.19.4 Product Listing
    • 10.19.5 Entropy
  • 10.20 Koning Health
    • 10.20.1 Company Overview
    • 10.20.2 Company Snapshot
    • 10.20.3 Financial Overview
    • 10.20.4 Product Listing
    • 10.20.5 Entropy

11. KOL Views

12. Project Approach

13. About DelveInsight

14. Disclaimer & Contact Us

List of Tables

  • Table 1: Brain Imaging Devices Market in Global (2022-2032)
  • Table 2: Brain Imaging Devices Market in Global by Product Type (2022-2032)
  • Table 3: Brain Imaging Devices Market in Global by Potability (2022-2032)
  • Table 4: Brain Imaging Devices Market in Global by Application (2022-2032)
  • Table 5: Brain Imaging Devices Market in Global by End-User (2022-2032)
  • Table 6: Brain Imaging Devices Market in Global by Geography (2022-2032)
  • Table 7: Brain Imaging Devices Market in North America (2022-2032)
  • Table 8: Brain Imaging Devices Market in the United States (2022-2032)
  • Table 9: Brain Imaging Devices Market in Canada (2022-2032)
  • Table 10: Brain Imaging Devices Market in Mexico (2022-2032)
  • Table 11: Brain Imaging Devices Market in Europe (2022-2032)
  • Table 12: Brain Imaging Devices Market in France (2022-2032)
  • Table 13: Brain Imaging Devices Market in Germany (2022-2032)
  • Table 14: Brain Imaging Devices Market in United Kingdom (2022-2032)
  • Table 15: Brain Imaging Devices Market in Italy (2022-2032)
  • Table 16: Brain Imaging Devices Market in Spain (2022-2032)
  • Table 17: Brain Imaging Devices Market in the Rest of Europe (2022-2032)
  • Table 18: Brain Imaging Devices Market in Asia-Pacific (2022-2032)
  • Table 19: Brain Imaging Devices Market in China (2022-2032)
  • Table 20: Brain Imaging Devices Market in Japan (2022-2032)
  • Table 21: Brain Imaging Devices Market in India (2022-2032)
  • Table 22: Brain Imaging Devices Market in Australia (2022-2032)
  • Table 23: Brain Imaging Devices Market in South Korea (2022-2032)
  • Table 24: Brain Imaging Devices Market in Rest of Asia-Pacific (2022-2032)
  • Table 25: Brain Imaging Devices Market in the Rest of the World (2022-2032)
  • Table 26: Brain Imaging Devices Market in the Middle East (2022-2032)
  • Table 27: Brain Imaging Devices Market in Africa (2022-2032)
  • Table 28: Brain Imaging Devices Market in South America (2022-2032)
  • Table 29: Competitive Landscape
  • Table 30: Startup Funding & Investment Trends

List of Figures

  • Figure 1: Brain Imaging Devices Market Drivers
  • Figure 2: Brain Imaging Devices Market Restraints
  • Figure 3: Brain Imaging Devices Market Opportunities
  • Figure 4: AI-Powered Innovations in Brain Imaging Devices Market
  • Figure 5: US Tariff Impact on Brain Imaging Devices Market
  • Figure 6: Regulatory Analysis (US, EU, Japan, China)
  • Figure 7: Porter's Five Forces Analysis
  • Figure 8: Competitive Analysis
  • Figure 9: Brain Imaging Devices Market in Global (2022-2032)
  • Figure 10: Brain Imaging Devices Market in Global by Product Type (2022-2032)
  • Figure 11: Brain Imaging Devices Market in Global by Portability (2022-2032)
  • Figure 12: Brain Imaging Devices Market in Global by Application (2022-2032)
  • Figure 13: Brain Imaging Devices Market in Global by End-User (2022-2032)
  • Figure 14: Brain Imaging Devices Market in Global by Geography (2022-2032)
  • Figure 15: Brain Imaging Devices Market in North America (2022-2032)
  • Figure 16: Brain Imaging Devices Market in the United States (2022-2032)
  • Figure 17: Brain Imaging Devices Market in Canada (2022-2032)
  • Figure 18: Brain Imaging Devices Market in Mexico (2022-2032)
  • Figure 19: Brain Imaging Devices Market in Europe (2022-2032)
  • Figure 20: Brain Imaging Devices Market in France (2022-2032)
  • Figure 21: Brain Imaging Devices Market in Germany (2022-2032)
  • Figure 22: Brain Imaging Devices Market in United Kingdom (2022-2032)
  • Figure 23: Brain Imaging Devices Market in Italy (2022-2032)
  • Figure 24: Brain Imaging Devices Market in Spain (2022-2032)
  • Figure 25: Brain Imaging Devices Market in the Rest of Europe (2022-2032)
  • Figure 26: Brain Imaging Devices Market in Asia-Pacific (2022-2032)
  • Figure 27: Brain Imaging Devices Market in China (2022-2032)
  • Figure 28: Brain Imaging Devices Market in Japan (2022-2032)
  • Figure 29: Brain Imaging Devices Market in India (2022-2032)
  • Figure 30: Brain Imaging Devices Market in Australia (2022-2032)
  • Figure 31: Brain Imaging Devices Market in South Korea (2022-2032)
  • Figure 32: Brain Imaging Devices Market in Rest of Asia-Pacific (2022-2032)
  • Figure 33: Brain Imaging Devices Market in the Rest of the World (2022-2032)
  • Figure 34: Brain Imaging Devices Market in the Middle East (2022-2032)
  • Figure 35: Brain Imaging Devices Market in Africa (2022-2032)
  • Figure 36: Brain Imaging Devices Market in South America (2022-2032)
  • Figure 37: Competitive Landscape
  • Figure 38: Startup Funding & Investment Trends